These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 7420681)

  • 1. Clinical nephrotoxicity of tobramycin and gentamicin. A prospective study.
    Kumin GD
    JAMA; 1980 Oct; 244(16):1808-10. PubMed ID: 7420681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Double-blind comparison of the nephrotoxicity and auditory toxicity of gentamicin and tobramycin.
    Smith CR; Lipsky JJ; Laskin OL; Hellmann DB; Mellits ED; Longstreth J; Lietman PS
    N Engl J Med; 1980 May; 302(20):1106-9. PubMed ID: 6988713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Controlled comparison of gentamicin and tobramycin nephrotoxicity.
    Matzke GR; Lucarotti RL; Shapiro HS
    Am J Nephrol; 1983; 3(1):11-7. PubMed ID: 6340504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Once-daily dosed gentamicin is more nephrotoxic than once-daily dosed tobramycin in clinically infected patients.
    van Maarseveen E; van Buul-Gast MC; Abdoellakhan R; Gelinck L; Neef C; Touw D
    J Antimicrob Chemother; 2014 Sep; 69(9):2581-3. PubMed ID: 24872345
    [No Abstract]   [Full Text] [Related]  

  • 5. Renal toxicity. Tobramycin and gentamicin.
    Fry TL; Fried FA; Goven BA
    Invest Urol; 1977 Sep; 15(2):100-3. PubMed ID: 903207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative nephrotoxicity of gentamicin and tobramycin: pharmacokinetic and clinical studies in 201 patients.
    Schentag JJ; Plaut ME; Cerra FB
    Antimicrob Agents Chemother; 1981 May; 19(5):859-66. PubMed ID: 7294770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aminoglycoside nephrotoxicity: a double blind prospective randomized study of gentamicin and tobramycin.
    Feig PU; Mitchell PP; Abrutyn E; Brock SM; Carney WR; Graeber CW; Horak E; Lyons RW; Maher JF
    J Antimicrob Chemother; 1982 Sep; 10(3):217-26. PubMed ID: 6754682
    [No Abstract]   [Full Text] [Related]  

  • 8. Renal toxicity during therapy with gentamicin or tobramycin.
    Keys TF; Kurtz SB; Jones JD; Muller SM
    Mayo Clin Proc; 1981 Sep; 56(9):556-9. PubMed ID: 6115104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nephrotoxicity of gentamicin and tobramycin given once daily or continuously in dogs.
    Reiner NE; Bloxham DD; Thompson WL
    J Antimicrob Chemother; 1978 May; 4 Suppl A():85-101. PubMed ID: 659354
    [No Abstract]   [Full Text] [Related]  

  • 10. Experience with a once-daily dosing program of aminoglycosides in critically ill patients.
    Buijk SE; Mouton JW; Gyssens IC; Verbrugh HA; Bruining HA
    Intensive Care Med; 2002 Jul; 28(7):936-42. PubMed ID: 12122533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute Kidney Injury With Tobramycin-Impregnated Bone Cement Spacers in Prosthetic Joint Infections.
    Aeng ES; Shalansky KF; Lau TT; Zalunardo N; Li G; Bowie WR; Duncan CP
    Ann Pharmacother; 2015 Nov; 49(11):1207-13. PubMed ID: 26269097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal and auditory toxicity of high-dose, prolonged therapy with gentamicin and tobramycin in pseudomonas endocarditis.
    Tablan OC; Reyes MP; Rintelmann WF; Lerner AM
    J Infect Dis; 1984 Feb; 149(2):257-63. PubMed ID: 6421944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The absence of nephrotoxicity and differential nephrotoxicity between tobramycin and gentamicin.
    Kepczyk T; Ryan PJ; McAllister K; Otraje J
    South Med J; 1990 Oct; 83(10):1149-52. PubMed ID: 2218653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gentamicin and tobramycin in patients with various infections--nephrotoxicity.
    Kahlmeter G; Hallberg T; Kamme C
    J Antimicrob Chemother; 1978 May; 4 Suppl A():47-52. PubMed ID: 659349
    [No Abstract]   [Full Text] [Related]  

  • 15. Aminoglycoside pharmacokinetics: dosage requirements and nephrotoxicity in trauma patients.
    Townsend PL; Fink MP; Stein KL; Murphy SG
    Crit Care Med; 1989 Feb; 17(2):154-7. PubMed ID: 2914447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aminoglycoside-induced nephrotoxicity.
    Wargo KA; Edwards JD
    J Pharm Pract; 2014 Dec; 27(6):573-7. PubMed ID: 25199523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravenous injection of gentamicin and tobramycin without impairment of hearing.
    Dobbs SM; Mawer GE
    J Infect Dis; 1976 Aug; 134 Suppl():S114-7. PubMed ID: 972268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Update on drug therapy: IX. Gentamicin and tobramycin nephrotoxicity.
    Darr MS; Elenbaas JK
    J Am Med Womens Assoc (1972); 1981 Oct; 36(10):310-6. PubMed ID: 7346536
    [No Abstract]   [Full Text] [Related]  

  • 19. Nephrotoxicity After the Treatment of Periprosthetic Joint Infection With Antibiotic-Loaded Cement Spacers.
    Edelstein AI; Okroj KT; Rogers T; Della Valle CJ; Sporer SM
    J Arthroplasty; 2018 Jul; 33(7):2225-2229. PubMed ID: 29526331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peri-operative renal morbidity secondary to gentamicin and flucloxacillin chemoprophylaxis for hip and knee arthroplasty.
    Ross AD; Boscainos PJ; Malhas A; Wigderowitz C
    Scott Med J; 2013 Nov; 58(4):209-12. PubMed ID: 24215038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.